 (ICST)6 enrolled 1713 patients and demonstrated
signiÔ¨Åcantly increased periprocedural stroke risk for
transfemoral CAS (7.7%) compared with CEA (4.1%) in
neurologically symptomatic patients (P < .002). The risk
of any stroke or death less than 30 days after treatment
in the stenting group was more than twice that in the
endarterectomy group (